Nocturnal hypoxic stress activates invasive ability of monocytes in patients with obstructive sleep apnoea syndrome

Respirology

Volumn 14, Issue 5, 2009, Pages 689-694

  Tamaki, Shinji ^a   Yamauchi, Motoo ^a   Fukuoka, Atsuhiko ^a   Makinodan, Kiyoshi ^a   Koyama, Noriko ^a   Tomoda, Koichi ^a   Yoshikawa, Masanori ^a   Kimura, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Hypoxia; Monocyte; Sleep apnoea

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; CELL COUNT; CELL INVASION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; MALE; MONOCYTE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

ADULT; ANOXIA; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CELL COUNT; CELL MOVEMENT; CIRCADIAN RHYTHM; HUMANS; MALE; MIDDLE AGED; MONOCYTES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 68149114125     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01540.x     Document Type: Article

References (36)

1. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. 2001 163 : 19 25. (Pubitemid 32095247)
2. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988 94 : 9 14.
3. McNicholas WT, Bonsigore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur. Respir. J. 2007 29 : 156 78.
4. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur. Heart J. 2004 25 : 735 41.
5. Sasanabe R, Banno K, Otake K, Hasegawa R, Usui K et al. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens. Res. 2006 29 : 315 22.
6. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002 105 : 1135 43.
7. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001 104 : 503 16.
8. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999 340 : 115 26.
9. Young JL, Libby P, Schönbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb. Haemost. 2002 88 : 554 67.
10. Cesari M, Penninx BW, Newman AB, Krichevsky SB, Nicklas BJ et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC Study. Circulation 2003 108 : 2317 22.
11. Rollins BJ. Chemokines. Blood 1997 90 : 909 28.
12. Boring L, Gosling J, Clearly M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998 394 : 894 7.
13. Gerszten RE, Gercia-Zepeda EA, Lim YC, Yoshida M, Ding HA et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999 398 : 718 23.
14. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 1997 82 : 1313 16.
15. Ciftci TU, Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004 28 : 87 91.
16. Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y et al. Elevated production of tumor necrosis factor-α by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004 126 : 1473 9.
17. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T et al. Effect of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J. Appl. Physiol. 2003 94 : 179 84.
18. Hayashi M, Fujimoto K, Urushibata K, Takamizawa A, Kinoshita O et al. Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome. Respirology 2006 11 : 24 31.
19. Tamaki S, Fukuoka A, Makinodan K, Tomoda K, Yamauchi M et al. Production of TNF-α, MMPs and MCP-1 by monocytes and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS). Eur. Respir. J. 2004 24 (Suppl. 48 331s.
20. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am. J. Respir. Crit. Care Med. 2002 165 : 934 9.
21. Lattimore JD, Wilcox I, Nakhla S, Langenfeld M, Jessup W et al. Repetitive hypoxia increases lipid loading in human macrophages - a potentially atherogenic effect. Atherosclerosis 2005 179 : 255 9.
22. Havlir DV, Ellner JJ, Chervenak KA, Boom WH. Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis. J. Clin. Invest. 1991 87 : 729 33.
23. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987 47 : 3239 45.
24. Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T et al. Effect of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am. J. Med. 2000 109 : 562 7.
25. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005 112 : 2660 7.
26. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997 336 : 1066 71.
27. Monaco C, Paleolog E. Nuclear factor-kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc. Res. 2004 62 : 671 82.
28. Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 2006 174 : 824 30.
29. Delacourt C, Hérigault S, Delclaux C, Poncin A, Levame M et al. Protection against acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor. Am. J. Respir. Cell Mol. Biol. 2002 26 : 290 7.
30. Keck T, Balcom JH 4th., Fernández-del Castillo C, Antoniu BA, Warshaw AL. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 2002 122 : 188 201.
31. Hashida H, Takabayashi A, Kanai M, Adachi M, Kondo K et al. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology 2002 122 : 376 86.
32. Maldonado CJ, Palazzolo K, Taylor JD. A novel in vitro system to study extravasated tumor cell-induced angiogenesis. Pathol. Oncol. Res. 1998 4 : 225 9.
33. Porter KE, Naik J, Turner NA, Dickinson T, Thompson MM et al. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. J. Vasc. Surg. 2002 36 : 150 7.
34. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989 320 : 915 24.
35. Mine S, Tabata T, Wada Y, Fujisaki T, Iida T et al. Oxidized low density lipoprotein-induced LFA-1-dependent adhesion and transendothelial migration of monocytes via the protein kinase C pathway. Atherosclerosis 2002 160 : 281 8.
36. Suzuki T, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y et al. Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 2004 27 : 129 33.